ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Year 2000 Report; Implementation Depends On Adequate Funding Starting With FY 1986

July 12, 1985

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

In Brief: FASEB Report On Diet and Cancer Mortality Available; Don Poppke AO of Nursing Center

March 6, 1987

Caution Advised for Hormone Replacement Therapy

March 21, 1986

In Brief: Landers Needles Pauling on Vitamin C Study Results; David Goldenberg Heads N.J. Center

October 21, 1983

Preyer Supported For Chairmanship

January 26, 1979